Pharmacokinetics of selol, a new agent containing selenium, in rats

Drugs under Experimental and Clinical Research

Volumn 23, Issue 1, 1997, Pages 7-11

  Jastrzebski Z ^a   Czyzewska Szafran, H ^a   Remiszewska, M ^a   Fijalek, Z ^a   Fitak, B A ^b   Suchocki, P ^b  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ORGANOSELENIUM DERIVATIVE; SELENIUM; SELOL; UNCLASSIFIED DRUG;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; MALE; MEAN RESIDENCE TIME; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SELENIUM DEFICIENCY; SUBCUTANEOUS DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADRENAL GLANDS; ANIMALS; BRAIN; INJECTIONS, SUBCUTANEOUS; KIDNEY; LIVER; LUNG; MALE; MYOCARDIUM; RATS; RATS, WISTAR; REGRESSION ANALYSIS; SELENIUM; SELENIUM COMPOUNDS; SPECTROPHOTOMETRY, ATOMIC; SPLEEN; TESTIS; TISSUE DISTRIBUTION;

EID: 0040040647     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Cantor A.H., Scott M.L., Noguchi T. Biological availability of selenium in feedstuffs and selenium compounds for prevention of exudative diathesis in chicks. J. Nutr., 105, 96, 1975.
2. Dorado R.D., Aquino T.M., Porta E.A. Etfects of dietary selenium on preneoplastic and neoplastic hepatic and renal lesions chemically induced in rats. Fed. Proc., 43, 794, 1984.
3. El-Bayoumy K. Effects of organoselenium compounds on induction of mouse forestomach tumors by benzo(a)pyrene. Cancer Res., 45, 3631, 1985.
4. Flatt A., Pearce N., Thomson C.D. et al. Reduced selenium in asthmatic subjects in New Zealand. Thorax, 45, 95, 1990.
5. Hinks L.J., Young S., Clayton B. Trace element status in eczema and psoriasis. Clin. Exp. Dermatol., 12, 92, 1987.
6. Li Wan Po A., Maguire T. Selenium: clinical uses, toxicology and popular claims. Pharm. J., 244, 513, 1990.
7. Alexander A.R., Whanger P.D., Miller L.T. Bioavailability to rats of selinium in various tuna and wheat products. J. Nutr. 113, 196, 1983.
8. Jastrzȩbski Z, Czyżewska-Szafran H., Fijalek Z., Suchocki P., Fitak B.A. Toxicity studies of selol, a new selenium compound, in rats. Drugs Exptl. Clin. Res., XXI, 217, 1995.
9. Ihnat M. Atomic absorption spectrometric determination of selenium with carbon furnace atomization. Anal. Chim. Acta., 82, 293, 1976.
10. Schuirmann D.J. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J. Pharmacokinet. Biopharm., 15, 657, 1987.
11. Klevay L.M. The pharmacology of selenium. Pharmacol. Ther., 1, 211, 1976.
12. Johlin L., Edqvist L.E., Ekman L.G. et al. Blood glutathione-peroxidase levels in skin diseases: effect of selenium and vitamin E treatment. Acta Dermato-Venereol., 62, 211, 1982.
13. Overad K. et al. Selenium in human mammary carcinogenesis: a case-referent study. Eur. J. Cancer Prev., 27, 900, 1991.